Serum thrombopoietin levels in thrombocytopenic and non-thrombocytopenic patients with human immunodeficiency virus (HIV-1) infection

European Journal of Haematology

Volumn 63, Issue 4, 1999, Pages 245-250

  Espanol I ^a   Muniz Diaz E ^a   Margall, N ^a   Rabella, N ^a   Sambeat, M A ^b   Hernandez A ^a   Pujol Moix, Núria ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Autoimmune thrombocytopenic purpura (AITP); Human immunodeficiency virus (HIV); Thrombocytopenia; Thrombopoietin

Indexed keywords

THROMBOPOIETIN;

ADULT; ARTICLE; CELL PROLIFERATION; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

EID: 0032888561     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1999.tb01885.x     Document Type: Article

References (29)

1. 1. ZON LI, ARKIN C, GROOPMAN JE. Haematologic manifestations of the human immunodeficiency virus (HIV). Br J Haematol 1987;66:251-256.
2. 2. LANDONIO G, CIRASINO L, PRETE A, NASARI A, IBRIANAI M. Thrombocytopenia in HIV infection. Eur J Haematol 1993;50:239-240.
3. 3. RATNER L. Human immunodeficiency virus (HIV) associated autoimmune thrombocytopenic purpura: a review. Am J Med 1989;86:194-198.
4. 4. DOMINGUEZ A, GAMALLO G, GARCIA R, LÒPEZ-PASTOR A, PEÑA JM, VAZQUEZ JJ. Pathophysiology of HIV related thrombocytopenia: an analysis of 41 patients. J Clin Pathol 1994;47:999-1003.
5. 5. BORGIA G, REYNAUD L, CICCIARELLO S, et al. Thrombocytopenia and AIDS: possible direct role of HIV, AIDS 1996;10:1606-1607.
6. 6. SAUVAGE FJ, HASS PE, SPENCER SD, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-mpl ligand. Nature (London) 1994;369:533-538.
7. 7. LOK S, KAUSHANSKY K, HOLLY RD, et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature (London) 1994;369:565-368.
8. 8. BARTLEY TD, BOGENBERGER J, HUNT P, et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor mpl. Cell 1994;77:1117-1124.
9. 9. DEBILI N, WENDLING F, COSMAN D, et al. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 1995;85:391-401.
10. 10. DEBILI N, WENDLING F, KATZ A, et al. The mpl-ligand or thrombopoietin or megakaryocyte growth and development factor has both direct proliferative and differentiative activities on human rnegakaryocyte progenitors. Blood 1995;86:2516-2525.
11. 11. NAGATA Y, SHOZAKI Y, NAGAHISA H, NAGASAWA T, ABE T, TODOKORO K. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis. Thromb Haemostasis 1997;77:808-814.
12. 12. EMMONS RVB, REID DM, COHEN RL, et al. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996;87: 4068-4071.
13. 13. HOU M, ANDERSSON PO, STOCKELBERG D, MELLQVIST UH, RIDELL B, WADENVIK H. Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes. Br J Haematol 1998;101:420-424.
14. 14. EATON DL, DE SAUVAGE FJ. Thrombopoietin: The primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp Hematol 1997;25:1-7.
15. 15. VON DEM BORNE AEGKR, VERGHFUT FWA, OOSTERBOF F, RIESZ LE, BRUTEL DE LA RIVIERE A, ENGELFRIET CP. A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol 1978;35:195-207.
16. 16. NAGASAWA T, HASEGAWA Y, SHIMIZU S, et al. Serum thrombopoietin level is mainly regulated by megakaryocyte mass rather than platelet mass in human subjects. Br J Haematol 1998;101:242-244.
17. 17. ESPAÑOL I, HERNANDEZ A, CORTES M, MATEO J, PUJOL-MOIX N. Patients with thrombocytosis present normal or slightly elevated thrombopoietin levels. Haematologica 1999;84:312-316.
18. 18. SHIMODAIRA S, ISHIDA F, ICHIKAWA N, et al. Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis. Thromb Haemostasis 1996;76:545-548.
19. 19. ESPAÑOL I, MURILLO J, HERNANDEZ A, PUJOL-MOIX N. Thrombocytopenia of mainly peripheral origin: Assessment of thrombopoietin. Blood 1998;92 (Suppl.1):31a.
20. 20. BASCH RS, KOURI YH, KARPATKIN S. Expression of CD4 by human megakaryocytes. Proc Natl Acad Sci USA 1990;87:8085-8089.
21. 21. ZUCKER-FRANKLIN D, TEMIN CS, COOPER MC. Structural changes in the megakaryocytes of patients infected with human immunedeficiency virus (HIV-1). Am J Pathol 1989;134:1295-1303.
22. 22. LOUACHE BF, BETTAIEB A, HENRI A, et al. Infection of megakaryocytes by human immunodeficiency virus in seropositive patients with immune thrombocytopenic purpura. Blood 1991;78:1697-1705.
23. 23. CHELUCCI C, FEDERICO M, GUERRIERO R, et al. Productive human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/precursors and maturing megakaryocytes. Blood 1998;91:1225-1234.
24. 24. ESPAÑOL I, MUÑIZ-DIAZ E, GRACIA M, IBAÑEZ M, HERNÁNDEZ A, PUJOL-MOIX N. Serum thrombopoietin levels in autoimmune thrombocytopenic purpura. Transfusion Med 1998;8:251.
25. 25. BALLEM PJ, BELZBERG A, DEVINE DV, et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med 1992;327:1779-1784.
26. 26. BEHR T, BAIR HJ, BECKER W, WOLF F, SCHWAB J. Aetiology of HIV-associated thrombocytopenia. Lancet 1994;343:479.
27. 27. HARKER LA, MARZEC UM, NOVEMBRE F, et al. Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant megakaryocyte growth and development factor. Blood 1998;91:4427-4433.
28. 28. COLE JL, MARZEC UM, GUNTHEL CJ, et al. Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood 1998;91: 3239-3246.
29. 29. HARKER LA, CARTER RA, MARZEC UM, et al. Correction of thrombocytopenia and ineffective platelet production in patients infected with human immunodeficiency virus (HIV) by PEG-rHuMGDF therapy. Blood 1998;92 (Suppl.1):707a.